JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Perakizumab is a humanized monoclonal antibody that binds to IL17A and acts as an immunomodulator. It was developed for the treatment of psoriatic arthritis.